Websites Hosted in ns3.bms.com Nameserver
The Nameserver ns3.bms.com have a IP Address of 198.155.223.8 which is hosted on United States.
Bristol-Myers Squibb - A global biopharmaceutical company
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
129,870 
$ 52,800.00
Bristol-Myers Squibb Canada - Home
To discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
2,278,498 $ 240.00
Bristol-Myers Squibb | Home
Bristol-Myers Squibb é hoje uma BioPharma focada na produção de medicamentos inovadores que supram as necessidades médicas. Confira isso e mais: estudos clínicos, materiais de minimização de risco e um conteúdo exclusivo para profissionais de saúde.
2,137,819 $ 240.00
Bristol-Myers Squibb France
Bristol-Myers Squibb est une entreprise biopharmaceutique globale dont la mission est de découvrir, développer et mettre à disposition des médicaments innovants pour aider les patients à vaincre des maladies graves.
1,153,704 $ 720.00
BMSPAF: Bristol-Myers Squibb Patient Assistance Foundation
The Bristol-Myers Squibb Patient Assistance Foundation is a non-profit organization that provides temporary assistance to qualifying patients with a financial hardship who generally have no private prescription drug insurance.
3,363,226 $ 240.00
ELIQUIS® (apixaban) | Official Site | Safety Info
ELIQUIS is used to reduce the risk of stroke & blood clots in people who have AFib, not due to a heart valve problem. Read Important Safety & Prescribing Info including Boxed WARNING & Medication Guide.
962,938 $ 720.00
ORENCIA® (abatacept) Official Site
ORENCIA® (abatacept), official website; learn about rheumatoid arthritis and how to take ORENCIA. Use live chat to answer your questions and review Important Safety Information and Prescribing Information
1,571,289 $ 480.00
COUMADIN (warfarin sodium) tablets
Learn about COUMADIN and read Important Safety Information and access Prescribing Information including BOXED WARNING and Medication Guide.
1,429,514 $ 480.00
Hep C Study Connect - Home
Overview of hepatitis C and why a clinical study may be an option for some people.
Not Applicable $ 8.95
SPRYCEL® (dasatinib)
SPRYCEL® (dasatinib) is a prescription medicine used to treat adults who have newly diagnosed Ph+ CML in chronic phase. The effectiveness of SPRYCEL in these patients is based on certain response rates from a 1-year study that is ongoing to look at results over a longer period of time. SPRYCEL is also approved for...
3,027,052 $ 240.00